TrialJournal of clinical pharmacology2021

Exposure-Response Analyses for Upadacitinib Efficacy in Subjects With Atopic Dermatitis-Analyses of Phase 2b Study to Support Selection of Phase 3 Doses.

Mohamed-Eslam F Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.